AI assistant
Sending…
Protara Therapeutics, Inc. — Director's Dealing 2015
Jun 3, 2015
34057_dirs_2015-06-03_78352d1e-7514-4d05-ac90-71e1d8e20935.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2015-06-02
Reporting Person: Toner E. Scott (Senior VP of Marketing)
More from Protara Therapeutics, Inc.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27